AU2001274894A1 - Novel matrix metalloproteinases - Google Patents

Novel matrix metalloproteinases

Info

Publication number
AU2001274894A1
AU2001274894A1 AU2001274894A AU7489401A AU2001274894A1 AU 2001274894 A1 AU2001274894 A1 AU 2001274894A1 AU 2001274894 A AU2001274894 A AU 2001274894A AU 7489401 A AU7489401 A AU 7489401A AU 2001274894 A1 AU2001274894 A1 AU 2001274894A1
Authority
AU
Australia
Prior art keywords
matrix metalloproteinases
novel matrix
novel
metalloproteinases
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001274894A
Inventor
Jonas Ekblom
Erik Holmgren
Mats Kihlen
Tim Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of AU2001274894A1 publication Critical patent/AU2001274894A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001274894A 2000-05-22 2001-05-22 Novel matrix metalloproteinases Abandoned AU2001274894A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20611900P 2000-05-22 2000-05-22
US60/206,119 2000-05-22
PCT/US2001/016563 WO2001090326A2 (en) 2000-05-22 2001-05-22 Novel matrix metalloproteinases

Publications (1)

Publication Number Publication Date
AU2001274894A1 true AU2001274894A1 (en) 2001-12-03

Family

ID=22765058

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001274894A Abandoned AU2001274894A1 (en) 2000-05-22 2001-05-22 Novel matrix metalloproteinases

Country Status (4)

Country Link
US (3) US6734005B2 (en)
EP (1) EP1297112A2 (en)
AU (1) AU2001274894A1 (en)
WO (1) WO2001090326A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU6063900A (en) * 1999-09-10 2001-04-10 Millennium Pharmaceuticals, Inc. Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
AU2001292601A1 (en) 2000-09-08 2002-03-22 Millennium Pharmaceuticals, Inc. Human matrix metalloproteinase
GB0209896D0 (en) * 2002-04-30 2002-06-05 Molmed Spa Conjugate
GB0209893D0 (en) * 2002-04-30 2002-06-05 Molmed Spa Conjugate
AU2008338421A1 (en) 2007-12-17 2009-06-25 Dyax Corp. Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins
JP2011517662A (en) 2008-03-03 2011-06-16 ダイアックス コーポレーション Metalloprotease 9 binding protein
WO2009111508A2 (en) * 2008-03-03 2009-09-11 Dyax Corp. Metalloproteinase 9 and metalloproteinase 2 binding proteins
WO2010079340A2 (en) * 2009-01-08 2010-07-15 Eisai R & D Management Co., Ltd. Assay
EP2403523A1 (en) * 2009-03-06 2012-01-11 Halozyme, Inc. Temperature sensitive mutants of matrix metalloprotease 1 und uses thereof
US10314909B2 (en) 2011-10-21 2019-06-11 Dyax Corp. Combination therapy comprising an MMP-14 binding protein
JP6188390B2 (en) * 2013-04-10 2017-08-30 積水メディカル株式会社 Method for measuring MMP-3
ES2620702B2 (en) * 2017-03-29 2017-12-18 Universidad De Cantabria Gene construction and its use in the treatment of cardiac fibrosis

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4879236A (en) 1984-05-16 1989-11-07 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US5242794A (en) 1984-12-13 1993-09-07 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
WO1990005183A1 (en) 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
DE69034135T3 (en) 1989-12-22 2012-08-23 Laboratoires Serono S.A. DNA constructs to activate and alter the expression of endogenous genes
AU651596B2 (en) 1990-06-05 1994-07-28 Immunex Corporation Type II interleukin-1 receptors
AU664847B2 (en) 1991-05-15 1995-12-07 Cell Genesys, Inc. Genomic modifications with homologous DNA targeting
ES2313867T3 (en) 1991-12-02 2009-03-16 Medical Research Council ANTI-AUTO ANTIBODY PRODUCTION OF ANTIBODY SEGMENT REPERTORIES EXPRESSED ON THE PAYMENT SURFACE.
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US5585277A (en) 1993-06-21 1996-12-17 Scriptgen Pharmaceuticals, Inc. Screening method for identifying ligands for target proteins
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
AU1662595A (en) 1994-01-28 1995-08-15 Herbert Altmann Method of determining the activity of a regulatory factor, and use of the method
GB9501567D0 (en) 1995-01-26 1995-03-15 Pharmacia Spa Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
GB9518220D0 (en) 1995-09-06 1995-11-08 Medical Res Council Checkpoint gene
US6017757A (en) 1997-02-20 2000-01-25 Mississippi State University Isolated viable nematode intestinal cells
WO1998040475A1 (en) * 1997-03-11 1998-09-17 Abbott Laboratories Human matrix metalloprotease gene, proteins encoded therefrom and methods of using same
CA2344464A1 (en) 1998-09-29 2000-04-06 Motoharu Seiki Dnas encoding novel polypeptides
FR2797890A1 (en) 1999-08-31 2001-03-02 Pf Medicament NEW MATRIX METALLOPROTEASE MMP-24 APPROVED WITH STROMELYSINS

Also Published As

Publication number Publication date
WO2001090326A3 (en) 2003-01-16
EP1297112A2 (en) 2003-04-02
US20030032164A1 (en) 2003-02-13
US20060275869A1 (en) 2006-12-07
WO2001090326A2 (en) 2001-11-29
US6734005B2 (en) 2004-05-11
US20040146499A1 (en) 2004-07-29
US7070976B2 (en) 2006-07-04

Similar Documents

Publication Publication Date Title
AU2002254085A1 (en) Switch matrix
AU2001271427A1 (en) Novel proteases
AU2002218266A1 (en) Novel indanylidene compounds
AU2001292518A1 (en) Novel compounds
AU2001258349A1 (en) Bisacylguanidine
AU2001239765A1 (en) Novel compounds
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001274894A1 (en) Novel matrix metalloproteinases
AU2001246998A1 (en) Novel compounds
AU2001253362A1 (en) Novel compounds
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2002231077A1 (en) Novel compounds
AU2001254731A1 (en) Substituted phenyluracils
AU2001256964A1 (en) Novel compounds
AU2002210379A1 (en) Subtilase variants
AU2001230689A1 (en) Novel compounds
AU2001291761A1 (en) Microcapsules
AU2002221923A1 (en) Novel compounds
AU2002216060A1 (en) Novel compounds
AU2001276890A1 (en) Novel compounds
AU4620300A (en) Can
AU2001292601A1 (en) Human matrix metalloproteinase
AU2001233317A1 (en) One-by-n switch matrix
AU2002219846A1 (en) Novel use